Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



MDT Medtronic PLC's Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and Neuromodulation Segments

February 26, 2025
Medtronic PLC, a global leader in medical technology, recently announced its Q3 2025 earnings call highlights, showcasing strong growth in its cardiac and neuromodulation segments. The company reported impressive revenue growth, driven by innovative products and expanding market opportunities.

In the cardiac segment, Medtronic witnessed a significant increase in sales of its advanced cardiac devices, such as pacemakers and defibrillators. This growth can be attributed to the rising incidence of cardiovascular diseases and the increasing adoption of these life-saving devices by healthcare professionals worldwide.

Moreover, Medtronic's neuromodulation segment also experienced robust growth, driven by the successful launch of its revolutionary adaptive brain stimulation technology for Parkinson's disease. This breakthrough treatment has received FDA approval, further solidifying Medtronic's position as a pioneer in neurostimulation therapies.

The company's strong performance in these key segments is a testament to its commitment to innovation and its focus on meeting the evolving needs of patients and healthcare providers. With a diverse portfolio of products and a strong pipeline of new advancements, Medtronic remains well-positioned for continued growth in the medical technology sector.

Investors looking to capitalize on Medtronic's success and potential for future growth may consider consulting with professionals from Stocks Prognosis for expert analysis and forecasts on the movement of the company's stocks. Their comprehensive market research and insights can help investors make informed decisions and maximize their investment returns.

Disclaimer: The views and recommendations mentioned in this article are for informational purposes only and should not be construed as professional investment advice. Investing in stocks carries risks, and individuals should conduct their own research and consult with financial experts before making any investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for MDT

Related data

MDTJuly 22, 2025QuantWave Successfully Predicts 8.91% Profit on MEDTRONIC PLC Stock  ~2 min.

QuantWave, the leading automated forecasting platform, has once again demonstrated its accuracy with the successful prediction of a price target for MEDTRONIC PLC....


MDTJuly 22, 2025Medical Device Giant MEDTRONIC PLC Hits Price Target Forecast, Generating 8.01% Profit  ~1 min.

On May 2, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC when it was trading at $84.85....


MDTJuly 11, 2025QuantWave Forecast Hits the Mark: MEDTRONIC PLC Achieves 4.98% Profit Target  ~2 min.

On May 20, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC with a price of $85.66. Fast forward to July 11, 2025, and the stock had surged to $89....


MDTJuly 10, 2025QuantWave Forecast Achieves 5.91% Profit Target for MEDTRONIC PLC  ~1 min.

On May 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for MEDTRONIC PLC (MDT) when the stock was trading at $84.41....


MDTJuly 10, 2025Profit Alert: MEDTRONIC PLC Stock Hits Price Target with 6.79% Gain  ~1 min.

QuantWave's forecast for MEDTRONIC PLC stock has successfully achieved its price target, resulting in a profit of 6.79%. The forecast signal date was 2025-05-21, with a price of 83....


MDTJuly 9, 2025QuantWave Successfully Hits Price Target Forecast for MEDTRONIC PLC with Profit of 4.89%  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has achieved yet another milestone with the successful prediction and realization of a price target forecast for MEDTRONIC PLC....


MDTJuly 9, 2025QuantWave Forecasts Success: MEDTRONIC PLC Price Target Hit with 6.65% Profit  ~1 min.

On May 5, 2025, QuantWave issued a long signal for MEDTRONIC PLC when the stock was priced at 83.45 $. The forecast proved to be accurate as the target of 89....


MDTJuly 9, 2025QuantWave Successfully Achieves Forecast Price Target for MEDTRONIC PLC with 7.54% Profit  ~2 min.

On May 5, 2025, QuantWave, the automated forecasting platform, issued a long signal for the stock of MEDTRONIC PLC at a price of 82.76 $....


MDTJuly 9, 2025QuantWave Successfully Achieves 5.76% Profit Target for MEDTRONIC PLC  ~1 min.

In an impressive display of accuracy, QuantWave, the automated forecasting platform, has successfully reached its price target forecast for MEDTRONIC PLC....


MDTJuly 6, 2025Medtronic PLC Enters Strategic Partnership with Philips to Expand Patient Monitoring Technology  ~1 min.

Medtronic PLC has recently announced a strategic partnership with Philips to enhance access to patient monitoring technology....


FORDDecember 20, 2024Neuvotion Expands AI-Driven Neurotech Partnership and Secures Investment for NeuStim Launch  ~2 min.

Forward Industries, Inc., through its subsidiary IPS (Intelligent Product Solutions), has announced further expansion of its AI-driven neurotech partnership with Neuvotion....


MDTFebruary 25, 2025Medtronic reports strong growth in cardiac and neuromodulation segments in Q3 2025  ~2 min.

Medtronic PLC, a global leader in medical technology, has announced its financial results for the third quarter of fiscal year 2025....


ABTDecember 3, 2024Abbott Laboratories Develops New Breakthrough in Medical Technology  ~2 min.

Abbott Laboratories, a leading global healthcare company, has announced a groundbreaking innovation in medical technology....


MDTFebruary 27, 2025Medtronic plc MDT: Revolutionary Adaptive Brain Stimulation System for Parkinson's Disease Receives FDA Approval  ~1 min.

Medtronic, a leader in medical technology, has recently earned the U.S. FDA's approval for its groundbreaking adaptive deep brain stimulation system for individuals with Parkinson's disease....


ABTJanuary 2, 2025Abbott Laboratories Announces Breakthrough in Medical Technology  ~2 min.

Abbott Laboratories, a renowned pharmaceutical and medical devices company, has recently unveiled a groundbreaking advancement in medical technology....